Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases

Details for Australian Patent Application No. 2008207659 (hide)

Owner Celgene Corporation

Inventors Zeldis, Jerome B.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008207659

Parent 2003290652

Filing date 1 September 2008

Wipo publication date 25 September 2008

International Classifications

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/00 (2006.01)

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4035 (2006.01)

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/425 (2006.01) - Thiazoles

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/454 (2006.01)

A61K 31/515 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

18 September 2008 Complete Application Filed

25 September 2008 Application Open to Public Inspection

  Published as AU-A-2008207659

2 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008207660-Review layouts

2008207658-Multi-Port Valve